Table 2. Worm burdens in Cry5B treatment experiments.
Group (no. of mice) | Intestinal worm burden (mean ± sem) | % Reduction relative to placebo | |
HD1 | placebo (10) | 59.1±11.1 | NA |
Cry5B (10) | 19.4±3.6 | 67.2 | |
4Q7 | placebo (7) | 169.1±14.0 | NA |
Cry5B (7) | 48.1±15.3 | 71.5 |
placebo: crystal-deficient HD1 or 4Q7 strain; Cry5B: the corresponding strain transformed with a Cry5B-expressing plasmid. Cry5B dosage: 715 nm/kg (HD1) or 644 nm/kg (4Q7).
sem = standard error of the mean.
NA = not applicable.